Skip to content
Search AI Powered

Latest Stories

WHO unveils comprehensive guidelines to help millions quit tobacco

WHO unveils comprehensive guidelines to help millions quit tobacco
The new WHO guidelines on tobacco cessation aims to enhance global access to effective cessation aids, underscoring WHO's commitment to addressing disparities in healthcare access

"Combining pharmacotherapy with behavioural interventions significantly increases quitting success rates," new World Health Organization (WHO) guidelines on tobacco cessation highlight.

In a landmark move, the WHO has unveiled comprehensive guidelines to assist the more than 750 million people worldwide seeking to quit tobacco use.


This first-ever guideline on tobacco cessation advocates for a holistic approach, integrating behavioural support, digital interventions, and pharmacological treatments to address the  global health issue.

Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, highlighted the significance of these guidelines in the ongoing battle against tobacco-related diseases.

"This guideline marks a crucial milestone in our global battle against these dangerous products," he stated.

"It empowers countries with the essential tools to effectively support individuals in quitting tobacco and alleviate the global burden of tobacco-related diseases.."

Despite the widespread desire to quit tobacco, according to the WHO over 70 per cent of those attempting cessation lack access to adequate support services.

This is primarily due to resource constraints within healthcare systems.

The WHO's guideline have urged governments to prioritise accessibility by offering medications such as varenicline, Nicotine Replacement Therapy (NRT), bupropion, and cytisine at reduced or no cost, particularly in low- and middle-income countries.

Since initiating a prequalification procedure for tobacco cessation medications in 2023, the WHO has recently approved Kenvue's nicotine gum and patch as the first WHO-prequalified NRT products.

This step aims to enhance global access to effective cessation aids, underscoring WHO's commitment to addressing disparities in healthcare access.

Behavioural interventions also play a crucial role in the guidelines, advocating for brief counselling sessions in healthcare settings and more intensive support through individual, group, or telephonic counselling.

Digital interventions, such as smartphone applications and online programs, are recommended as additional support tools throughout the quitting process.

Dr. Rüdiger Krech, WHO's Director of Health Promotion, emphasised the collaborative effort required to tackle tobacco use.

"These guidelines are designed to empower communities and governments to provide the best possible support for individuals on this challenging journey," he stressed.

The release of WHO's comprehensive tobacco cessation guidelines represents a significant step towards reducing the global burden of tobacco-related diseases and improving public health worldwide.

Healthcare providers, policymakers, and stakeholders are urged to adopt and implement these guidelines to support millions in achieving tobacco-free lives.

More For You

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Prakash Patel was speaking at a panel discussion at the Sigma Conference

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Pharmacists need to be a part of integrated care boards (ICB) to stop GPs from monopolising services based on their needs rather than the needs of the patient, according to Prakash Patel, Community Pharmacy Engaland (CPE) representative for North London.

“The evolution of the NHS should mean there can be no decision of pharmacy without pharmacist,” Patel told delegates at the Sigma Pharmacy Conference in Baku, Azerbaijan on Tuesday.

Keep ReadingShow less
David Webb
David Webb, NHS England's Chief Pharmaceutical Officer
David Webb, NHS England's Chief Pharmaceutical Officer

Sigma Conference: "Community pharmacy ready to make a profound contribution to 10 Year Health Plan," says David Webb

A national community pharmacy prescribing service remains a long-term goal of the government, according to NHS chief pharmaceutical officer, David Webb.

The Labour Party in its election manifesto last year said it would “create a Community Pharmacist Prescribing Service, granting more pharmacists independent prescribing rights”.

Keep ReadingShow less
New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less